Recommended Topic Related To:

Zavesca

"The U.S. Food and Drug Administration today notified Ranbaxy Laboratories, Ltd., that it is prohibited from manufacturing and distributing active pharmaceutical ingredients (APIs) from its facility in Toansa, India, for FDA-regulated drug product"...

Zavesca

Zavesca Patient Information including If I Miss a Dose

What happens if I miss a dose (Zavesca)?

If you miss a dose of miglustat, skip the missed dose and only take the next regularly scheduled dose. Do not take a double dose of this medication unless otherwise directed by your doctor.

What happens if I overdose (Zavesca)?

Seek emergency medical attention if an overdose is suspected.

Symptoms of a miglustat overdose are not well known but may include dizziness, numbness and tingling, and blood problems.

What should I avoid while taking miglustat (Zavesca)?

There are no restrictions on food, beverages, or activity during treatment with miglustat unless otherwise directed by your doctor.

What other drugs will affect miglustat (Zavesca)?

Miglustat is not intended for use with imiglucerase (Cerezyme), another treatment for type 1 Gaucher disease.

There are no known interactions between miglustat and other medications. Talk to your doctor or pharmacist before taking any other prescription or over-the-counter medications, including vitamins, minerals, and herbal products, during treatment with miglustat.

Where can I get more information?

Your pharmacist can provide more information about miglustat.


Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.

Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 1996-2013 Cerner Multum, Inc. Version: 3.02. Revision date: 12/15/2010.

Your use of the content provided in this service indicates that you have read,understood and agree to the End-User License Agreement,which can be accessed by clicking on this link.

Healthwise

Side Effects Centers
A A A

Additional Zavesca Information

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.